Drugging the efferocytosis process: concepts and opportunities
Open accessAbstract
The daily removal of billions of apoptotic cells in the human body via the process of efferocytosis is essential for homeostasis. To allow for this continuous efferocytosis, rapid phenotypic changes occur in the phagocytes enabling them to engulf and digest the apoptotic cargo. In addition, efferocytosis is actively anti-inflammatory and promotes resolution. Owing to its ubiquitous nature and the sheer volume of cell turnover, efferocytosis is a point of vulnerability. Aberrations in efferocytosis are associated with numerous inflammatory pathologies, including atherosclerosis, cancer and infections. The recent exciting discoveries defining the molecular machinery involved in efferocytosis have opened many avenues for therapeutic intervention, with several agents now in clinical trials.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Efferocytosis in other settings can promote fibrosis as part of tissue resolution, for example, by secreting TGF-β1.
“efferocytosis in other settings can promote fibrosis as part of the tissue resolution process, for example, by secreting TGF-β1 (12, 13).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [13]
The Digestion phase says efferocytosis-associated signalling increases macrophage TGFβ expression, and the Cancer section describes possible TGFβ release by macrophages engulfing apoptotic cells. These passages support the secretion mechanism, but they do not say that efferocytosis promotes fibrosis during tissue resolution or identify the cytokine specifically as TGF-β1. Page numbers are unavailable in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measuredNo approaches targeting efferocytosis have thus far been clinically approved.
“While some progress has been made with respect to the Fractalkine receptor (CX3C motif chemokine receptor 1), Axl, MerTK, CD47 and Tim4/3, no approaches have thus far been clinically approved (64).”
From Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells (2026) · cites this paper as [64]
Table 1 (Approaches to target the eating phase; page unavailable) lists therapeutics targeting Axl, MerTK, CD47 and TIM4/3 as being in clinical trials, supporting the distinction between progress in trials and clinical approval. The Introduction (page unavailable) also says an autologous apoptotic-cell approach is already in use. The review does not establish the broader claim that no approach targeting efferocytosis has been clinically approved. (LLM, conf=0.78)
Experimental — accuracy not yet measuredAccumulation of dead cells in disease indicates impaired clearance by macrophages.
“The accumulation of dead cells in disease settings indicates impaired clearance of dead cells by macrophages (“efferocytosis”) (12, 13).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [13]
Efferocytosis prevents dead cell accumulation and reprograms macrophages for tissue resolution, and its impairment contributes to many chronic inflammatory diseases.
“Efferocytosis not only prevents dead cell accumulation but also reprograms macrophages to execute tissue resolution functions, and impaired efferocytosis contributes to many human chronic inflammatory diseases (12, 13).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [13]
Efferocytosis is seen as a major hurdle to using antigen presenting cells in cell-based therapies.
“It is seen as a major hurdle to using antigen presenting cells in cell-based therapies (61–64).”
From Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells (2026) · cites this paper as [64]
The Cancer section describes efferocytosis as a challenge for antitumour drug development, and the Infectious diseases section reports reduced antigen presentation by dendritic cells in a specific infection. Neither passage addresses whether efferocytosis is a major hurdle to using antigen-presenting cells in cell-based therapies. Searches for antigen-presenting cells and cell-based therapies found no passage making that connection. (LLM, conf=0.72)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Tan, X., Zhang, Z., Yao, H., & Shen, L. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.012 · Cited by 76 · see citing works
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Cappello, V., Marchetti, L., Parlanti, P., Landi, S., Tonazzini, I., Cecchini, M., Piazza, V., & Gemmi, M. (2016) · Scientific Reports · doi:10.1038/s41598-016-0001-8 · Cited by 13,097 · see citing works
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360 · see citing works
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · see citing works
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,365 · see citing works
Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J., Bratton, D. L., & Henson, P. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.2207 · Cited by 3,321 · see citing works
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303 · see citing works
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119 · see citing works
Geroscience: Linking Aging to Chronic Disease
Kennedy, B. K., Berger, S. L., Brunet, A., Campisi, J., Cuervo, A. M., Epel, E. S., Franceschi, C., Lithgow, G. J., Morimoto, R. I., Pessin, J. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.039 · Cited by 2,764 · see citing works
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,359 · see citing works
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Gordon, S. R., Maute, R. L., Dulken, B. W., Hutter, G., George, B. M., McCracken, M. N., Gupta, R., Tsai, J. M., Sinha, R., Corey, D., et al. (2017) · Nature · doi:10.1038/nature22396 · Cited by 2,247 · see citing works
Necroptosis and its role in inflammation
Pasparakis, M., & Vandenabeele, P. (2015) · Nature · doi:10.1038/nature14191 · Cited by 2,148 · see citing works
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Giamarellos-Bourboulis, E. J., Netea, M. G., Rovina, N., Akinosoglou, K., Antoniadou, A., Antonakos, N., Damoraki, G., Gkavogianni, T., Adami, M.-E., Katsaounou, P., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.009 · Cited by 2,045 · see citing works
Four faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,016 · see citing works
Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752 · see citing works
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Elliott, M. R., Chekeni, F. B., Trampont, P. C., Lazarowski, E. R., Kadl, A., Walk, S. F., Park, D., Woodson, R. I., Ostankovich, M., Sharma, P., et al. (2009) · Nature · doi:10.1038/nature08296 · Cited by 1,654 · see citing works
Self-citationThe role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642 · see citing works
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D. J., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,578 · see citing works
Middleton, E. A., He, X., Denorme, F., Campbell, R. A., Ng, D. C., Salvatore, S., Mostyka, M., Baxter-Stoltzfus, A., Borczuk, A., Loda, M. F., et al. (2020) · Blood · doi:10.1182/blood.2020007008 · Cited by 1,482 · see citing works
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Schulte-Schrepping, J., Reusch, N., Paclik, D., Baßler, K., Schlickeiser, S., Zhang, B., Krämer, B., Krammer, T., Brumhard, S., Bonaguro, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.001 · Cited by 1,461 · see citing works
Sica, A., Schioppa, T., Mantovani, A., & Allavena, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.003 · Cited by 1,451 · see citing works
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Barkal, A. A., Brewer, R. E., Markovic, M., Kowarsky, M., Barkal, S. A., Zaro, B. W., Krishnan, V., Hatakeyama, J., Dorigo, O., Barkal, L. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1456-0 · Cited by 1,391 · see citing works
Senescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284 · see citing works
Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype
Wiley, C. D., Velarde, M. C., Lecot, P., Liu, S., Sarnoski, E. A., Freund, A., Shirakawa, K., Lim, H. W., Davis, S. S., Ramanathan, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.11.011 · Cited by 1,275 · see citing works
HIV preferentially infects HIV-specific CD4+ T cells
Douek, D. C., Brenchley, J. M., Betts, M. R., Ambrozak, D. R., Hill, B. J., Okamoto, Y., Casazza, J. P., Kuruppu, J. C., Kunstman, K., Wolinsky, S. M., et al. (2002) · Nature · doi:10.1038/417095a · Cited by 1,261 · see citing works
Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection
Doitsh, G., Galloway, N. L. K., Geng, X., Yang, Z., Monroe, K. M., Zepeda, O., Hunt, P. W., Hatano, H., Sowinski, S., Muñoz-Arias, I., et al. (2013) · Nature · doi:10.1038/nature12940 · Cited by 1,181 · see citing works
Living on a break: cellular senescence as a DNA-damage response
d'Adda di Fagagna, F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2440 · Cited by 1,170 · see citing works
Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis
Chekeni, F. B., Elliott, M. R., Sandilos, J. K., Walk, S. F., Kinchen, J. M., Lazarowski, E. R., Armstrong, A. J., Penuela, S., Laird, D. W., Salvesen, G. S., et al. (2010) · Nature · doi:10.1038/nature09413 · Cited by 1,120 · see citing works
Self-citationChao, M. P., Alizadeh, A. A., Tang, C. Z., Myklebust, J. H., Varghese, B., Gill, S. I., Jan, M., Cha, A. C., Chan, C. K. F., Tan, B. T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.044 · Cited by 1,095 · see citing works
Efferocytosis in health and disease
Doran, A. C., Yurdagul, A., & Tabas, I. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0240-6 · Cited by 1,066 · see citing works
TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response
Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B. A., & Lemke, G. (2007) · Cell · doi:10.1016/j.cell.2007.10.034 · Cited by 1,055 · see citing works
Lauber, K., Bohn, E., Kröber, S. M., Xiao, Y.-J., Blumenthal, S. G., Lindemann, R. K., Marini, P., Wiedig, C., Zobywalski, A., Baksh, S., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00422-7 · Cited by 967 · see citing works
Phagocytosis of apoptotic cells in homeostasis
Arandjelovic, S., & Ravichandran, K. S. (2015) · Nature Immunology · doi:10.1038/ni.3253 · Cited by 959 · see citing works
Self-citationSynthetic LXR ligand inhibits the development of atherosclerosis in mice
Joseph, S. B., McKilligin, E., Pei, L., Watson, M. A., Collins, A. R., Laffitte, B. A., Chen, M., Noh, G. J., Goodman, J., Hagger, G. N., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112059299 · Cited by 950 · see citing works
The clearance of dead cells by efferocytosis
Boada-Romero, E., Martinez, J., Heckmann, B. L., & Green, D. R. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0232-1 · Cited by 893 · see citing works
Immunobiology of the TAM receptors
Lemke, G., & Rothlin, C. V. (2008) · Nature reviews. Immunology · doi:10.1038/nri2303 · Cited by 867 · see citing works
BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module
Park, D., Tosello‐Trampont, A., Elliott, M. R., Lu, M., Haney, L. B., Ma, Z., Klibanov, A. L., Mandell, J. W., & Ravichandran, K. S. (2007) · Nature · doi:10.1038/nature06329 · Cited by 848 · see citing works
Self-citationSLC Transporters as Therapeutic Targets: Emerging Opportunities
Lin, L., Yee, S. W., Kim, R. B., & Giacomini, K. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4626 · Cited by 835 · see citing works
An Apoptotic ‘Eat Me’ Signal: Phosphatidylserine Exposure
Segawa, K., & Nagata, S. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.08.003 · Cited by 778 · see citing works
Hayflick, his limit, and cellular ageing
Shay, J. W., & Wright, W. E. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036093 · Cited by 764 · see citing works
Immunogenic cell death in cancer therapy: Present and emerging inducers
Zhou, J., Wang, G., Chen, Y., Wang, H., Hua, Y., & Cai, Z. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14356 · Cited by 715 · see citing works
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Graham, D. K., DeRyckere, D., Davies, K. D., & Earp, H. S. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3847 · Cited by 708 · see citing works
Macrophage Dysfunction Impairs Resolution of Inflammation in the Wounds of Diabetic Mice
Khanna, S., Biswas, S., Shang, Y., Collard, E., Azad, A., Kauh, C., Bhasker, V., Gordillo, G. M., Sen, C. K., & Roy, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009539 · Cited by 694 · see citing works
TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells.
Kobayashi, N., Karisola, P., Peña-Cruz, V., Dorfman, D., Jinushi, M., Umetsu, S., Butte, M., Nagumo, H., Chernova, I., Zhu, B., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.011 · Cited by 688 · see citing works
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
Kojima, Y., Volkmer, J.-P., McKenna, K., Civelek, M., Lusis, A. J., Miller, C. L., Direnzo, D., Nanda, V., Ye, J., Connolly, A. J., et al. (2016) · Nature · doi:10.1038/nature18935 · Cited by 683 · see citing works
A-González, N., Bensinger, S. J., Hong, C., Beceiro, S., Bradley, M. N., Zelcer, N., Deniz, J. M., Ramírez, C. M., Díaz, M., Gallardo, G., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.018 · Cited by 674 · see citing works
Tseng, D., Volkmer, J.-P., Willingham, S. B., Contreras-Trujillo, H., Fathman, J. W., Fernhoff, N. B., Seita, J., Inlay, M. A., Weiskopf, K., Miyanishi, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305569110 · Cited by 656 · see citing works
Zizzo, G., Hilliard, B. A., Monestier, M., & Cohen, P. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200662 · Cited by 650 · see citing works
Immune modulation by mesenchymal stem cells
Jiang, W., & Xu, J. (2020) · Cell Proliferation · doi:10.1111/cpr.12712 · Cited by 650 · see citing works
Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., & Brady, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1663 · Cited by 638 · see citing works
Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells
Glass, C. K., & Saijo, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2748 · Cited by 619 · see citing works
Lagunas‐Rangel, F. A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25819 · Cited by 606 · see citing works
Xk-Related Protein 8 and CED-8 Promote Phosphatidylserine Exposure in Apoptotic Cells
Suzuki, J., Denning, D. P., Imanishi, E., Horvitz, H. R., & Nagata, S. (2013) · Science · doi:10.1126/science.1236758 · Cited by 573 · see citing works
Barkal, A. A., Weiskopf, K., Kao, K. S., Gordon, S. R., Rosental, B., Yiu, Y. Y., George, B. M., Markovic, M., Ring, N. G., Tsai, J. M., et al. (2017) · Nature Immunology · doi:10.1038/s41590-017-0004-z · Cited by 560 · see citing works
Holland, S. J., Pan, A., Franci, C., Hu, Y., Chang, B. Y., Li, W., Duan, M., Torneros, A., Yu, J., Heckrodt, T. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2997 · Cited by 554 · see citing works
Lauber, K., Blumenthal, S. G., Waibel, M., & Wesselborg, S. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00237-0 · Cited by 552 · see citing works
The TIM and TAM Families of Phosphatidylserine Receptors Mediate Dengue Virus Entry
Meertens, L., Carnec, X., Perera-Lecoin, M., Ramdasi, R., Guivel‐Benhassine, F., Lew, E. D., Lemke, G., Schwartz, O., & Amara, A. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.08.009 · Cited by 526 · see citing works
Yurdagul, A., Subramanian, M., Wang, X., Crown, S. B., Ilkayeva, O. R., Darville, L., Kolluru, G. K., Rymond, C. C., Gerlach, B. D., Zheng, Z., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.001 · Cited by 525 · see citing works
Arabpour, M., Saghazadeh, A., & Rezaei, N. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107823 · Cited by 516 · see citing works
Metabolites released from apoptotic cells act as tissue messengers
Medina, C. B., Mehrotra, P., Arandjelovic, S., Perry, J. S. A., Guo, Y., Morioka, S., Barron, B. J., Walk, S. F., Ghesquière, B., Krupnick, A. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2121-3 · Cited by 513 · see citing works
Self-citationEngineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies
Weiskopf, K., Ring, A. M., Ho, C. C. M., Volkmer, J.-P., Levin, A. M., Volkmer, A. K., Özkan, E., Fernhoff, N. B., van de Rijn, M., Weissman, I. L., et al. (2013) · Science · doi:10.1126/science.1238856 · Cited by 493 · see citing works
Tsai, R. K., & Discher, D. E. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200708043 · Cited by 486 · see citing works
Zhang, S., Weinberg, S., DeBerge, M., Gainullina, A., Schipma, M., Kinchen, J. M., Ben-Sahra, I., Gius, D. R., Yvan-Charvet, L., Chandel, N. S., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.004 · Cited by 485 · see citing works
SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy
Veillette, A., & Chen, J. (2018) · Trends in Immunology · doi:10.1016/j.it.2017.12.005 · Cited by 476 · see citing works
CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis
Truman, L. A., Ford, C. A., Pasikowska, M., Pound, J. D., Wilkinson, S. J., Dumitriu, I. E., Melville, L., Melrose, L. A., Ogden, C. A., Nibbs, R., et al. (2008) · Blood · doi:10.1182/blood-2008-06-162404 · Cited by 473 · see citing works
Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages
Freire-de-Lima, C. G., Nascimento, D. O., Soares, M. B. P., Bozza, P. T., Castro-Faria-Neto, H. C., Mello, F. G. D., DosReis, G. A., & Lopes, M. F. (2000) · Nature · doi:10.1038/35003208 · Cited by 455 · see citing works
Efferocytosis Signaling in the Regulation of Macrophage Inflammatory Responses
Elliott, M. R., Koster, K. M., & Murphy, P. S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601520 · Cited by 440 · see citing works
Cutting Edge: Neutrophil Granulocyte Serves as a Vector for <i>Leishmania</i> Entry into Macrophages
van Zandbergen, G., Klinger, M., Mueller, A., Dannenberg, S., Gebert, A., Solbach, W., & Laskay, T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6521 · Cited by 430 · see citing works
Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1.
Terai, C., Kornbluth, R. S., Pauza, C. D., et al. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115188 · Cited by 426 · see citing works
Fredman, G., Hellmann, J., Proto, J. D., Kuriakose, G., Colas, R. A., Dorweiler, B., Connolly, E. S., Solomon, R., Jones, D. M., Heyer, E. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms12859 · Cited by 411 · see citing works
Pinti, M., Cevenini, E., Nasi, M., De Biasi, S., Salvioli, S., Monti, D., Benatti, S., Gibellini, L., Cotichini, R., Stazi, M. A., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201343921 · Cited by 409 · see citing works
Living on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology
Morioka, S., Maueröder, C., & Ravichandran, K. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.04.018 · Cited by 391 · see citing works
Self-citationApoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment
Brown, S., Heinisch, I., Ross, E., Shaw, K., Buckley, C. D., & Savill, J. (2002) · Nature · doi:10.1038/nature00811 · Cited by 390 · see citing works
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
Braga, L., Ali, H., Secco, I., Chiavacci, E., Neves, G., Goldhill, D. H., Penn, R., Jiménez-Guardeño, J. M., Ortega‐Prieto, A. M., Bussani, R., et al. (2021) · Nature · doi:10.1038/s41586-021-03491-6 · Cited by 389 · see citing works
Kondratowicz, A. S., Lennemann, N. J., Sinn, P. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019030108 · Cited by 377 · see citing works
Calcium-dependent Phospholipid Scramblase Activity of TMEM16 Protein Family Members
Suzuki, J., Fujii, T., Imao, T., Ishihara, K., Kuba, H., & Nagata, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.457937 · Cited by 373 · see citing works
Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release
Morioka, S., Perry, J. S. A., Raymond, M. H., Medina, C. B., Zhu, Y., Zhao, L., Serbulea, V., Önengüt-Gümüşcü, S., Leitinger, N., Kucenas, S., et al. (2018) · Nature · doi:10.1038/s41586-018-0735-5 · Cited by 370 · see citing works
Self-citationGude, D., Alvarez, S. E., Paugh, S. W., Mitra, P., Yu, J., Griffiths, R., Barbour, S. E., Milstien, S., & Spiegel, S. (2008) · The FASEB Journal · doi:10.1096/fj.08-107169 · Cited by 364 · see citing works
Mitochondrial fission promotes the continued clearance of apoptotic cells by macrophages
Wang, Y., Subramanian, M., Yurdagul, A., Barbosa-Lorenzi, V. C., Cai, B., de Juan-Sanz, J., Ryan, T. A., Nomura, M., Maxfield, F. R., & Tabas, I. (2017) · Cell · doi:10.1016/j.cell.2017.08.041 · Cited by 364 · see citing works
Efferocytosis induces macrophage proliferation to help resolve tissue injury
Gerlach, B. D., Ampomah, P. B., Yurdagul, A., Liu, C., Lauring, M. C., Wang, X., Kasikara, C., Kong, N., Shi, J., Tao, W., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.10.015 · Cited by 360 · see citing works
Hall, B. M., Balan, V., Gleiberman, A. S., Strom, E., Krasnov, P., Virtuoso, L. P., Rydkina, E., Vujcic, S., Balan, K., Gitlin, I., et al. (2016) · Aging · doi:10.18632/aging.100991 · Cited by 357 · see citing works
The clearance of dying cells: table for two
Green, D. R., Oguin, T. H., & Martinez, J. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.172 · Cited by 314 · see citing works
The Dynamics of Apoptotic Cell Clearance
Elliott, M. R., & Ravichandran, K. S. (2016) · Developmental Cell · doi:10.1016/j.devcel.2016.06.029 · Cited by 314 · see citing works
Self-citationAsiedu, M. K., Beauchamp‐Perez, F., Ingle, J. N., Behrens, M. D., Radisky, D. C., & Knutson, K. L. (2013) · Oncogene · doi:10.1038/onc.2013.57 · Cited by 302 · see citing works
Thorp, E., Vaisar, T., Subramanian, M., Mautner, L., Blobel, C., & Tabas, I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.263020 · Cited by 298 · see citing works
Flores, A. M., Hosseini-Nassab, N., Jarr, K.-U., Ye, J., Zhu, X., Wirka, R. C., Koh, A. L., Tsantilas, P., Wang, Y., Nanda, V., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-019-0619-3 · Cited by 289 · see citing works
Hashimoto, Y., Moki, T., Takizawa, T., Shiratsuchi, A., & Nakanishi, Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2448 · Cited by 285 · see citing works
Efferocytosis Is an Innate Antibacterial Mechanism
Martin, C. J., Booty, M. G., Rosebrock, T. R., Nunes-Alves, C., Desjardins, D. M., Keren, I., Fortune, S. M., Remold, H. G., & Behar, S. M. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.06.010 · Cited by 285 · see citing works
LC3-associated phagocytosis at a glance
Heckmann, B. L., & Green, D. R. (2019) · Journal of Cell Science · doi:10.1242/jcs.222984 · Cited by 272 · see citing works
MDSC; the Most Important Cell You Have Never Heard Of
Tesi, R. J. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.10.008 · Cited by 265 · see citing works
MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis
Cai, B., Thorp, E. B., Doran, A. C., Sansbury, B. E., Daemen, M. J. A. P., Dorweiler, B., Spite, M., Fredman, G., & Tabas, I. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90520 · Cited by 262 · see citing works
Fujii, T., Sakata, A., Nishimura, S., Eto, K., & Nagata, S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516594112 · Cited by 254 · see citing works
MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation
Cai, B., Thorp, E. B., Doran, A. C., Subramanian, M., Sansbury, B. E., Lin, C., Spite, M. R., Fredman, G., & Tabas, I. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524292113 · Cited by 253 · see citing works
Ghazi, N. G., Abboud, E. B., Nowilaty, S. R., Alkuraya, H., Alhommadi, A., Cai, H., Hou, R., Deng, W.-T., Boye, S. L., Almaghamsi, A., et al. (2016) · Human Genetics · doi:10.1007/s00439-016-1637-y · Cited by 243 · see citing works
Filardy, A. A., Pires, D. R., Nunes, M. P., Takiya, C. M., Freire-de-Lima, C. G., Ribeiro-Gomes, F. L., & DosReis, G. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000017 · Cited by 237 · see citing works
Apoptotic cells induce Mer tyrosine kinase–dependent blockade of NF-κB activation in dendritic cells
Sen, P., Wallet, M. A., Yi, Z., Huang, Y., Henderson, M., Mathews, C. E., Earp, H. S., Matsushima, G. K., Baldwin, A. S., & Tisch, R. (2006) · Blood · doi:10.1182/blood-2006-04-017368 · Cited by 237 · see citing works
Dallenga, T. K., Repnik, U., Corleis, B., Eich, J., Reimer, R., Griffiths, G. W., & Schaible, U. E. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.09.003 · Cited by 231 · see citing works
Erythropoeitin Signaling in Macrophages Promotes Dying Cell Clearance and Immune Tolerance
Luo, B., Gan, W., Liu, Z., Shen, Z., Wang, J., Shi, R., Liu, Y., Liu, Y., Jiang, M., Zhang, Z., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.002 · Cited by 229 · see citing works
Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS
Grégoire, M., Uhel, F., Lesouhaitier, M., Gacouin, A., Guirriec, M., Mourcin, F., Dumontet, E., Chalin, A., Samson, M., Berthelot, L., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.02590-2017 · Cited by 219 · see citing works
Henson, P. M. (2017) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125315 · Cited by 208 · see citing works
Morizono, K., Xie, Y., Olafsen, T., Lee, B., Dasgupta, A., Wu, A. M., & Chen, I. S. Y. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.03.012 · Cited by 207 · see citing works
Constitutive exposure of phosphatidylserine on viable cells
Segawa, K., Suzuki, J., & Nagata, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114799108 · Cited by 203 · see citing works
Medina, C. B., & Ravichandran, K. S. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.13 · Cited by 196 · see citing works
Self-citationSegain, J., de la Blétière, D. R., Sauzeau, V., Bourreille, A., Hilaret, G., Cario‐Toumaniantz, C., Pacaud, P., Galmiche, J., & Loirand, G. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00283-x · Cited by 189 · see citing works
MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis
Cook, R. S., Jacobsen, K. M., Wofford, A., DeRyckere, D., Stanford, J. C., Prieto, A. L., Redente, E. F., Sandahl, M. A., Hunter, D. M., Strunk, K. E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67655 · Cited by 186 · see citing works
Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly
De Maeyer, R. P. H., van de Merwe, R. C., Louie, R., Bracken, O. V., Devine, O. P., Goldstein, D. R., Uddin, M., Akbar, A. N., & Gilroy, D. W. (2020) · Nature Immunology · doi:10.1038/s41590-020-0646-0 · Cited by 182 · see citing works
Cai, B., Kasikara, C., Doran, A. C., Ramakrishnan, R., Birge, R. B., & Tabas, I. (2018) · Science Signaling · doi:10.1126/scisignal.aar3721 · Cited by 175 · see citing works
Arnardottir, H. H., Dalli, J., Colas, R. A., Shinohara, M., & Serhan, C. N. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401313 · Cited by 171 · see citing works
Exposure of Phosphatidylserine by Xk-related Protein Family Members during Apoptosis
Suzuki, J., Imanishi, E., & Nagata, S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.583419 · Cited by 171 · see citing works
Ageing is associated with diminished apoptotic cell clearancein vivo
Aprahamian, T. R., Takemura, Y., Goukassian, D. A., & Walsh, K. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03658.x · Cited by 168 · see citing works
Post‐traumatic osteoarthritis: The role of accelerated chondrocyte senescence
Martin, J. A., Brown, T., Heiner, A., & Buckwalter, J. A. (2004) · Biorheology: The Official Journal of the International Society of Biorheology · doi:10.1177/0006355x2004041003004017 · Cited by 168 · see citing works
Li, S., Sun, Y., Liang, C., Thorp, E. B., Han, S., Jehle, A. W., Saraswathi, V., Pridgen, B. C., Kanter, J. E., Li, R., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.199570 · Cited by 167 · see citing works
Lee, Y. Y., Park, H. H., Park, W., Kim, H., Jang, J. G., Hong, K. S., Lee, J., Seo, H. S., Na, D. H., Kim, T. H., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120389 · Cited by 165 · see citing works
Extracorporeal Photopheresis After Lung Transplantation: A 10-Year Single-Center Experience
Benden, C., Speich, R., Hofbauer, G. F. L., et al. (2008) · Transplantation · doi:10.1097/tp.0b013e31818bc024 · Cited by 162 · see citing works
Harding, J. J., Moreno, V., Bang, Y.-J., Hong, M. H., Patnaik, A., Trigo, J., Szpurka, A. M., Yamamoto, N., Doi, T., Fu, S., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4405 · Cited by 161 · see citing works
The Phosphatidylserine Receptor TIM-4 Does Not Mediate Direct Signaling
Park, D., Hochreiter, A. E., & Ravichandran, K. S. (2009) · Current Biology · doi:10.1016/j.cub.2009.01.042 · Cited by 158 · see citing works
Self-citationTibrewal, N., Wu, Y., D’Mello, V., Akakura, R., George, T. C., Varnum, B. C., & Birge, R. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706906200 · Cited by 156 · see citing works
Engulfment of Apoptotic Cells Is Negatively Regulated by Rho-mediated Signaling
Tosello‐Trampont, A., Nakada‐Tsukui, K., & Ravichandran, K. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306079200 · Cited by 153 · see citing works
Self-citationAXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs
Wilson, C., Ye, X., Pham, T., Lin, E., Chan, S., McNamara, E., Neve, R. M., Belmont, L., Koeppen, H., Yauch, R. L., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1009 · Cited by 150 · see citing works
Listeria monocytogenes exploits efferocytosis to promote cell-to-cell spread
Czuczman, M. A., Fattouh, R., van Rijn, J. M., Canadien, V., Osborne, S. E., Muise, A. M., Kuchroo, V. K., Higgins, D. E., & Brumell, J. H. (2014) · Nature · doi:10.1038/nature13168 · Cited by 150 · see citing works
MerTK is required for apoptotic cell–induced T cell tolerance
Wallet, M. A., Sen, P., Flores, R. R., Wang, Y., Yi, Z., Huang, Y., Mathews, C. E., Earp, H. S., Matsushima, G. K., Wang, B., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20062293 · Cited by 149 · see citing works
Pro-Resolving Mediators in Regulating and Conferring Macrophage Function
Dalli, J., & Serhan, C. N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01400 · Cited by 147 · see citing works
Molecular Pathways: MERTK Signaling in Cancer
Cummings, C. T., DeRyckere, D., Earp, H. S., & Graham, D. K. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1451 · Cited by 138 · see citing works
Holtzhausen, A., Harris, W. P., Ubil, E., Hunter, D. M., Zhao, J., Zhang, Y., Zhang, D., Liu, Q., Wang, X., Graham, D. K., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0008 · Cited by 132 · see citing works
Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus
Hartl, J., Serpas, L., Wang, Y., Rashidfarrokhi, A., Perez, O. A., Sally, B., Sisirak, V., Soni, C., Khodadadi‐Jamayran, A., Tsirigos, A., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201138 · Cited by 130 · see citing works
Phosphatidylserine receptors enhance SARS-CoV-2 infection
Bohan, D., Ert, H. A. V., Ruggio, N., Rogers, K. J., Badreddine, M., Aguilar-Briseño, J. A., Elliff, J. M., Chávez, R. A. R., Gao, B., Stokowy, T., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009743 · Cited by 129 · see citing works
Resolvin D1 promotes the targeting and clearance of necroptotic cells
Gerlach, B. D., Marinello, M., Heinz, J., Rymut, N., Sansbury, B. E., Riley, C. O., Sadhu, S., Hosseini, Z., Kojima, Y., Tang, D. D., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0370-1 · Cited by 128 · see citing works
Boosting Apoptotic Cell Clearance by Colonic Epithelial Cells Attenuates Inflammation In Vivo
Lee, C. S., Penberthy, K. K., Wheeler, K. M., Juncadella, I. J., Vandenabeele, P., Lysiak, J. J., & Ravichandran, K. S. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.005 · Cited by 124 · see citing works
Self-citationLarsson, M., Fonteneau, J., Lirvall, M., et al. (2002) · AIDS · doi:10.1097/00002030-200207050-00003 · Cited by 120 · see citing works
Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production
Viaud, M., Ivanov, S., Vujić, N., Duta-Mare, M., Aira, L., Barouillet, T., Garcia, E., Orange, F., Dugail, I., Hainault, I., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312333 · Cited by 120 · see citing works
Suresh Babu, S., Thandavarayan, R. A., Joladarashi, D., Jeyabal, P., Krishnamurthy, S., Bhimaraj, A., Youker, K. A., & Krishnamurthy, P. (2016) · Scientific Reports · doi:10.1038/srep36207 · Cited by 119 · see citing works
The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes
Tang, C., & Oram, J. F. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.03.011 · Cited by 116 · see citing works
Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1
Fond, A. M., Lee, C. S., Schulman, I. G., Kiss, R. S., & Ravichandran, K. S. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80300 · Cited by 114 · see citing works
Self-citationPark, S., Yun, Y., Lim, J.-S., Kim, M. J., Kim, S.-Y., Kim, J.-E., & Kim, I.-S. (2016) · Nature Communications · doi:10.1038/ncomms10871 · Cited by 114 · see citing works
Doran, A. C., Özcan, L., Cai, B., Zheng, Z., Fredman, G., Rymond, C. C., Dorweiler, B., Sluimer, J. C., Hsieh, J., Kuriakose, G., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94735 · Cited by 113 · see citing works
Resolvin D1 promotes efferocytosis in aging by limiting senescent cell‐induced MerTK cleavage
Rymut, N., Heinz, J., Sadhu, S., Hosseini, Z., Riley, C. O., Marinello, M., Maloney, J., MacNamara, K. C., Spite, M. R., & Fredman, G. (2019) · The FASEB Journal · doi:10.1096/fj.201902126r · Cited by 113 · see citing works
He, Y., Xu, H., Liang, L., Zhan, Z., Yang, X., Yu, X., Ye, Y., & Sun, L. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23986 · Cited by 112 · see citing works
Putting the brakes on phagocytosis: “don't-eat-me” signaling in physiology and disease
Kelley, S. M., & Ravichandran, K. S. (2021) · EMBO Reports · doi:10.15252/embr.202152564 · Cited by 110 · see citing works
Self-citationInterpreting an apoptotic corpse as anti-inflammatory involves a chloride sensing pathway
Perry, J. S. A., Morioka, S., Medina, C. B., Etchegaray, J. I., Barron, B. J., Raymond, M. H., Lucas, C. D., Önengüt-Gümüşcü, S., Delpire, E. J., & Ravichandran, K. S. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0431-1 · Cited by 105 · see citing works
Self-citationXian, X., Ding, Y., Dieckmann, M., Zhou, L., Plattner, F., Liu, M., Parks, J. S., Hammer, R. E., Boucher, P., Tsai, S. X., et al. (2017) · eLife · doi:10.7554/elife.29292 · Cited by 103 · see citing works
Brunner, A. M., Esteve, J., Porkka, K., et al. (2021) · Blood · doi:10.1182/blood-2021-146039 · Cited by 103 · see citing works
Unsaturated Fatty Acids Phosphorylate and Destabilize ABCA1 through a Phospholipase D2 Pathway
Wang, Y., & Oram, J. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506210200 · Cited by 101 · see citing works
MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system
Huelse, J. M., Fridlyand, D. M., Earp, S. H., DeRyckere, D., & Graham, D. K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107577 · Cited by 101 · see citing works
Yamaguchi, H., Maruyama, T., Urade, Y., & Nagata, S. (2014) · eLife · doi:10.7554/elife.02172 · Cited by 100 · see citing works
Conlon, T. J., Deng, W., Erger, K. E., Cossette, T. L., Pang, J., Ryals, R. C., Clément, N., Cleaver, B. D., McDoom, I., Boye, S. L., et al. (2013) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2013.037 · Cited by 99 · see citing works
Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C δ pathway
Wang, Y., & Oram, J. F. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600437-jlr200 · Cited by 98 · see citing works
ATP11C is a major flippase in human erythrocytes and its defect causes congenital hemolytic anemia
Arashiki, N., Takakuwa, Y., Mohandas, N., et al. (2016) · Haematologica · doi:10.3324/haematol.2016.142273 · Cited by 98 · see citing works
Tzelepis, F., Verway, M. J., Daoud, J., Gillard, J., Hassani‐Ardakani, K., Dunn, J. L., Downey, J., Gentile, M., Jaworska, J., Sanchez, A. M. J., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci77014 · Cited by 93 · see citing works
Kumar, S., Calianese, D. C., & Birge, R. B. (2017) · Immunological Reviews · doi:10.1111/imr.12587 · Cited by 92 · see citing works
Nishi, C., Yanagihashi, Y., Segawa, K., & Nagata, S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006628 · Cited by 92 · see citing works
TIM-family proteins inhibit HIV-1 release
Li, M., Ablan, S. D., Miao, C., Zheng, Y.-M., Fuller, M. S., Rennert, P. D., Maury, W. J., Johnson, M. C., Freed, E. O., & Liu, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404851111 · Cited by 85 · see citing works
Orme, J. J., Du, Y., Vanarsa, K., Mayeux, J., Li, L., Mutwally, A., Arriens, C., Min, S., Hutcheson, J., Davis, L. S., et al. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.05.011 · Cited by 84 · see citing works
Apoptosis inhibition by intracellular bacteria and its consequence on host immunity
Behar, S. M., & Briken, V. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.05.007 · Cited by 84 · see citing works
Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages
Marques-da-Silva, C., Burnstock, G., Ojcius, D. M., et al. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.03.010 · Cited by 83 · see citing works
Köröskényi, K., Duró, E., Pallai, A., Sarang, Z., Kloor, D., Ucker, D. S., Beceiro, S., Castrillo, A., Chawla, A., Ledent, C. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002284 · Cited by 83 · see citing works
Minson, K. A., Smith, C. C., DeRyckere, D., Libbrecht, C., Lee‐Sherick, A. B., Huey, M. G., Lasater, E. A., Kirkpatrick, G. D., Stashko, M. A., Zhang, W., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85630 · Cited by 81 · see citing works
Prevalence of a mutation causing C2 deficiency in systemic lupus erythematosus.
Sullivan, K. E., Petri, M. A., Schmeckpeper, B. J., McLean, R. H., & Winkelstein, J. A. (1994) · PubMed · Cited by 81 · see citing works
Komura, H., Miksa, M., Wu, R., Goyert, S. M., & Wang, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.581 · Cited by 80 · see citing works
Regression of Inflammation in Atherosclerosis by the LXR Agonist R211945
Vucic, E., Calcagno, C., Dickson, S. D., Rudd, J. H. F., Hayashi, K., Bucerius, J. A., Moshier, E. L., Mounessa, J. S., Roytman, M., Moon, M. J., et al. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.11.025 · Cited by 78 · see citing works
Cui, D., Thorp, E., Li, Y., Wang, N., Yvan-Charvet, L., Tall, A. R., & Tabas, I. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0307192 · Cited by 73 · see citing works
Garbin, U., Baggio, E., Stranieri, C., Pasini, A., Manfro, S., Mozzini, C., Vallerio, P., Lipari, G., Merigo, F., Guidi, G. C., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs301 · Cited by 72 · see citing works
Role of TIM-4 in exosome-dependent entry of HIV-1 into human immune cells
Sims, B., Farrow, A. L., Williams, S. D., Bansal, A., Krendelchtchikov, A., Gu, L., & Matthews, Q. L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s132762 · Cited by 70 · see citing works
Singla, B., Lin, H., Ahn, W., Xu, J., Ma, Q., Sghayyer, M., Dong, K., Cherian‐Shaw, M., Zhou, J., Huo, Y., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab369 · Cited by 70 · see citing works
Roumenina, L. T., Sène, D., Radanova, M. A., Blouin, J., Halbwachs‐Mecarelli, L., Dragon‐Durey, M., Fridman, W. H., & Frémeaux‐Bacchi, V. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101749 · Cited by 69 · see citing works
Billings, E. A., Lee, C. S., Owen, K. A., D’Souza, R. S., Ravichandran, K. S., & Casanova, J. E. (2016) · Science Signaling · doi:10.1126/scisignal.aac6250 · Cited by 68 · see citing works
Self-citationBrunner, A. M., Esteve, J., Porkka, K., Knapper, S., Vey, N., Scholl, S., Garcia‐Manero, G., Wermke, M., Janssen, J., Traer, E. A., et al. (2020) · Blood · doi:10.1182/blood-2020-136855 · Cited by 68 · see citing works
Salina, A. C. G., dos-Santos, D., Rodrigues, T. S., Fortes-Rocha, M., Filho, E. G. F., Alzamora-Terrel, D. L., de Castro, Í. M. S., Fraga‐Silva, T. F. D. C., de Lima, M. H., Nascimento, D. C., et al. (2022) · eLife · doi:10.7554/elife.74443 · Cited by 67 · see citing works
Tourki, B., Kain, V., Pullen, A. B., Norris, P. C., Patel, N., Arora, P. K., Leroy, X., Serhan, C. N., & Halade, G. V. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.008 · Cited by 66 · see citing works
In situ neutrophil efferocytosis shapes T cell immunity to influenza infection
Lim, K., Kim, T., Trzeciak, A. J., Amitrano, A. M., Reilly, E. C., Prizant, H., Fowell, D. J., Topham, D. J., & Kim, M. (2020) · Nature Immunology · doi:10.1038/s41590-020-0746-x · Cited by 63 · see citing works
TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis
Brunton, B. A., Rogers, K. J., Phillips, E. K., Brouillette, R. B., Bouls, R., Butler, N. S., & Maury, W. J. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006983 · Cited by 61 · see citing works
Lupus-like autoimmune disease caused by a lack of Xkr8, a caspase-dependent phospholipid scramblase
Kawano, M., & Nagata, S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720732115 · Cited by 59 · see citing works
Zhao, W., Thacker, S. G., Hodgin, J. B., Zhang, H., Wang, J. H., Park, J. L., Randolph, A. E., Somers, E. C., Pennathur, S., Kretzler, M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804341 · Cited by 58 · see citing works
Medina, C. B., Chiu, Y., Stremska, M. E., Lucas, C. D., Poon, I. K. H., Tung, K. S. K., Elliott, M. R., Desai, B. N., Lorenz, U. M., Bayliss, D. A., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.06.014 · Cited by 57 · see citing works
Self-citationWu, D., Xu, J.-Z., Wu, Y., Lafarge, J.-C., Xiao, B., Gao, P., & Zhu, D. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.025 · Cited by 53 · see citing works
Fisher, G. A., Lakhani, N. J., Eng, C., Hecht, J. R., Bendell, J. C., Philip, P. A., O'Dwyer, P. J., Johnson, B., Kardosh, A., Ippolito, T. M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.4_suppl.114 · Cited by 53 · see citing works
Ribeiro-Gomes, F. L., Romano, A., Lee, S., Roffê, E., Peters, N. C., Debrabant, A., & Sacks, D. L. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.351 · Cited by 52 · see citing works
Ballantine, L. E., Midgley, A., Harris, D. A., Richards, E., Burgess, S., & Beresford, M. W. (2015) · Pediatric Rheumatology · doi:10.1186/s12969-015-0007-y · Cited by 51 · see citing works
Zhou, F., Jia, X., Yang, Q., et al. (2016) · Biomaterials Science · doi:10.1039/c5bm00629e · Cited by 50 · see citing works
Vouri, M., An, Q., Birt, M., Pilkington, G. J., & Hafizi, S. (2015) · Oncotarget · doi:10.18632/oncotarget.3952 · Cited by 49 · see citing works
Codo, A. C., Saraiva, A. C., dos Santos, L. L., Visconde, M. F., Gales, A. C., Zamboni, D. S., & de Medeiros, A. I. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1214-5 · Cited by 49 · see citing works
Li, Y., Wu, Y., Wang, Z., et al. (2010) · PubMed · Cited by 46 · see citing works
Yamashita, T., Asano, Y., Taniguchi, T., Nakamura, K., Saigusa, R., Miura, S., Toyama, T., Takahashi, T., Ichimura, Y., Yoshizaki, A., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.08.037 · Cited by 46 · see citing works
Chen, F., Song, Q., & Yu, Q. (2018) · Europe PMC (PubMed Central) · Cited by 45 · see citing works
Efferocytosis Creates a Tumor Microenvironment Supportive of Tumor Survival and Metastasis
(2015) · Cancer Cell & Microenvironment · doi:10.14800/ccm.666 · Cited by 44 · see citing works
TIM-4 promotes the growth of non-small-cell lung cancer in a RGD motif-dependent manner
Zhang, Q., Wang, H., Wu, X., Liu, B., Liu, W., Wang, R., Liang, X., Ma, C., & Gao, L. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.323 · Cited by 44 · see citing works
Luo, B., Wang, Z., Zhang, Z., Shen, Z., & Zhang, Z. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.005 · Cited by 42 · see citing works
Zhang, Z., Tian, H., Yang, C., Liu, J., Zhang, H., Wang, J., Hu, S., Sun, Z., He, K., & Chen, G. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014397 · Cited by 42 · see citing works
ELMO1 Regulates Autophagy Induction and Bacterial Clearance During Enteric Infection
Sarkar, A., Tindle, C., Pranadinata, R. F., Reed, S. L., Eckmann, L., Stappenbeck, T. S., Ernst, P. B., & Das, S. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix528 · Cited by 41 · see citing works
Multifaceted Roles of TIM-Family Proteins in Virus–Host Interactions
Evans, J. P., & Liu, S. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.10.004 · Cited by 41 · see citing works
TP-0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy
Aveic, S., Corallo, D., Porcù, E., et al. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.016 · Cited by 40 · see citing works
Tamgue, O., Gcanga, L., Ozturk, M., Whitehead, L., Pillay, S., Jacobs, R., Roy, S., Schmeier, S., Davids, M., Medvedeva, Y. A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00421 · Cited by 40 · see citing works
Phosphatidylserine receptor-targeting therapies for the treatment of cancer
Park, M., & Kang, K. W. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01167-4 · Cited by 39 · see citing works
Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment
Fernandez-Boyanapalli, R. F., Falcone, E. L., Zerbe, C. S., Marciano, B. E., Frasch, S. C., Henson, P. M., Holland, S. M., & Bratton, D. L. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.07.034 · Cited by 38 · see citing works
Navarini, L., Bisogno, T., Margiotta, D. P. E., Piccoli, A., Angeletti, S., Laudisio, A., Ciccozzi, M., Afeltra, A., & Maccarrone, M. (2018) · Journal of Immunology Research · doi:10.1155/2018/5264195 · Cited by 38 · see citing works
Adeno-Associated Viral Vectors and the Retina
Alexander, J. J., & Hauswirth, W. W. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-74904-4_13 · Cited by 37 · see citing works
Tanegashima, K., Sato‐Miyata, Y., Funakoshi, M., Nishito, Y., Aigaki, T., & Hara, T. (2016) · Genes to Cells · doi:10.1111/gtc.12456 · Cited by 37 · see citing works
TP-0903 is active in models of drug-resistant acute myeloid leukemia
Jeon, J. Y., Buelow, D. R., Garrison, D. A., Niu, M., Eisenmann, E. D., Huang, K. M., Thomas, M. E. Z., Weber, R. H., Whatcott, C. J., Warner, S. L., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.140169 · Cited by 35 · see citing works
Das, S., Sarkar, A., Choudhury, S. S., et al. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.02.003 · Cited by 34 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- [23]Urbani, L. et al. in Transplantation Proceedings 1175–1178 (Elsevier, 2004).
- [116]Dalli J Colas R Shinohara M Serhan CN Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving Medicines 2014 193 4235 4244 PMC4185223 25217168
- [192]Noelia A Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR Immunity 2009 31 245 258 10.1016/j.immuni.2009.06.018 19646905 PMC2791787 · DOI
Cited by
Sorted by citations
Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution
Sukka, S. R., Ampomah, P. B., Darville, L. N. F., Ngai, D., Wang, X., Kuriakose, G., Xiao, Y., Shi, J., Koomen, J. M., McCusker, R. H., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01115-7 · Cited by 82 · see citing works
Efferocytosis in liver disease
Shi, H., Moore, M. P., Wang, X., & Tabas, I. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2023.100960 · Cited by 30 · see citing works
Shi, H., Wang, X., Sloas, C., Gerlach, B., Yurdagul, A., Moore, M. P., Jung, E. J., Mirshahi, F., Ronzoni, L., Sanyal, A. J., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adv2106 · Cited by 30 · see citing works
Cao, C., Liu, W., Guo, X., Weng, S., Chen, Y., Luo, Y., Wang, S., Zhu, B., Liu, Y., & Peng, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1460431 · Cited by 16 · see citing works
Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells
Bendre, S. V., Wang, Y., Hajyousif, B., K C, R., Bhogale, S. G., Pradeep, D., Krawczynska, N., Schane, C. P., Weisser, E., Singh, A., et al. (2026) · Science Advances · doi:10.1126/sciadv.adx5490 · Cited by 8 · see citing works
“It is seen as a major hurdle to using antigen-presenting cells in cell-based therapies ( 73 – 76 ).”
- Authors
- Mehrotra, P., & Ravichandran, K. S.
- Affiliations
- VIB-UGent Center for Inflammation Research (BE)
- Washington University in St. Louis (US)
- Corresponding author
- Ravichandran, Kodi S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2022-06-01
- Volume
- 21
- Issue
- 8
- Pages
- 601-620
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC9157040
- OpenAlex
- W4281737563
- Cited by
- 459
- References
- 231
- Citations by year
- 2026: 130 · 2025: 153 · 2024: 104 · 2023: 66 · 2022: 6
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL120840)
- National Institute of General Medical Sciences (R35GM122542)
- National Institute of Allergy and Infectious Diseases (R01AI159551)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Keywords
- efferocytosis, phagocytes, anti-inflammatory mechanism, inflammation resolution, therapeutic target, atherosclerosis, cancer, infection
- MeSH terms
- Homeostasis, Humans, Phagocytes, Phagocytosis, Apoptosis, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review